These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Origin of plasma protoporphyrin in patients with erythropoietic protoporphyria. Johnson JA; Fusaro RM Arch Dermatol; 1981 Sep; 117(9):526-7. PubMed ID: 7294843 [No Abstract] [Full Text] [Related]
47. -Carotene as a treatment for photohypersensitivity due to erythropoietic protoporphyria. Baart de la Faille H; Suurmond D; Went LN; van Steveninck J; Schothorst AA Dermatologica; 1972; 145(6):389-94. PubMed ID: 4657758 [No Abstract] [Full Text] [Related]
48. beta-Carotene in the treatment of erythropoietic protoporphyria. A short review. Krook G; Haeger-Aronsen B Acta Derm Venereol Suppl (Stockh); 1982; 100():125-9. PubMed ID: 6819749 [TBL] [Abstract][Full Text] [Related]
49. [In vitro hemolysis in visible light in porphyria and light dermatosis without disorders of porphyrin metabolism]. Kalkoff KW; Buck A Hautarzt; 1967 Jan; 18(1):17-22. PubMed ID: 6047684 [No Abstract] [Full Text] [Related]
50. Erythropoietic protoporphyria provoked by iron therapy. Baker H Proc R Soc Med; 1971 Jun; 64(6):610-1. PubMed ID: 5090504 [No Abstract] [Full Text] [Related]
51. Erythropoietic protoporphyria exacerbated by oral iron therapy. Milligan A; Graham-Brown RA; Sarkany I; Baker H Br J Dermatol; 1988 Jul; 119(1):63-6. PubMed ID: 3408665 [TBL] [Abstract][Full Text] [Related]
52. Photoprotection in erythropoietic protoporphyria: mechanism of photoprotection by beta carotene. Moshell AN; Bjornson L J Invest Dermatol; 1977 Mar; 68(3):157-60. PubMed ID: 839088 [TBL] [Abstract][Full Text] [Related]
53. Photodynamic release of protoporphyrin from intact erythrocytes in erythropoietic protoporphyria: the effect of small repetitive light doses. Brun A; Sandberg S Photochem Photobiol; 1985 May; 41(5):535-41. PubMed ID: 4011707 [No Abstract] [Full Text] [Related]
54. Erythropoietic protoporphyria. A case report. Bhutani LK; Deshpande SG Dermatologica; 1973; 147(4):267-70. PubMed ID: 4780777 [No Abstract] [Full Text] [Related]
55. Carotenoid pigments and the treatment of erythropoietic protoporphyria. Mathews-Roth MM J Infect Dis; 1978 Dec; 138(6):924-7. PubMed ID: 739162 [TBL] [Abstract][Full Text] [Related]
56. Photohemolysis. The comparative behavior of erythrocytes from patients with different types of porphyria. Haining RG; Hulse TE; Labbe RF Proc Soc Exp Biol Med; 1969 Nov; 132(2):625-8. PubMed ID: 5355116 [No Abstract] [Full Text] [Related]
57. -Aminolevulinic acid synthetase activity in erythroblasts of patients with erythropoietic protoporphyria. Takaku F; Yano Y; Aoki Y; Nakao K; Wada O Nihon Ketsueki Gakkai Zasshi; 1971 Apr; 34(2):233-6. PubMed ID: 5170470 [No Abstract] [Full Text] [Related]
58. Inhibitory effect of plasma on photohaemolysis in erythropoietic protoporphyria. Joenje H; Woutersen RA; Baart de la Faille H Dermatologica; 1981; 163(4):285-94. PubMed ID: 7308550 [TBL] [Abstract][Full Text] [Related]
59. Erythropoietic protoporphyria (notes on a case). Gheorghiu G; Forsea D; Atanasiu-Costinescu M Rom Med Rev; 1969; 13(3):42-6. PubMed ID: 5359786 [No Abstract] [Full Text] [Related]
60. Studies on photohemolysis with special reference to demethylchlortetracycline. Bjellerup M; Ljunggren B Acta Derm Venereol; 1984; 64(5):378-83. PubMed ID: 6208714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]